Canadian Journal of Infectious Diseases and Medical Microbiology

Impact of infections on the success of hematopoietic stem cell transplantations


Publishing date
01 Nov 2020
Status
Open
Submission deadline
26 Jun 2020

1Children Hospital of México Federico Gómez, Mexico City, Mexico

2Pediatric Hematology Services, Hospital General "Gaudencio González Garza", CMN "La Raza", IMSS, Mexico City, Mexico

3School of Medicine and Health Sciences, Universidad del Rosario Bogotá, Bogotá, Colombia


Impact of infections on the success of hematopoietic stem cell transplantations


Call for papers

This Issue is now open for submissions.

Papers are published upon acceptance, regardless of the Special Issue publication date.

 Submit to this Special Issue

Description

Hematopoietic stem cell transplantation (HSCT) has been used successfully in the therapy of leukemia and other hematological malignancies, as well as in the assistance of patients undergoing high doses of chemotherapy in solid organ tumors. In addition to this, new reports have described the use of HSCT in HIV treatment. However, performing HSCT requires immunosuppressive conditions that put the patient at risk of bacterial, fungal and viral infections, in most cases refractory to antibacterial, antiviral or antifungal therapy. Patients are also at risk of emergence of microorganisms non-previously identified. In addition, the selection of antimicrobial therapy is limited and depends on the critical condition of the patient.

In this context, infections in HSCT patients still represent a high morbidity and mortality rate, which highly compromises the success of the graft, as well as the patient's life.

In this Special Issue we welcome submissions including original research articles, clinical studies and reviews of the highest quality that contribute new knowledge and innovative methods to provide a better handling and approach to these patients.

Potential topics include but are not limited to the following:

  • Pathogenesis of infectious agents in active infection and symptomatic infection in HSCT
  • Advantages and disadvantages of new molecular and immunological methods, as well as MALDI-TOF, used for diagnosing infections in patients with HSCT
  • New methods of treatment for infected patients undergoing HSCT
  • Adoptive therapy for viral infection in HSCT
  • Emerging pathogens in patients undergoing HSCT
  • Emergence of antimicrobial, antifungal or antiviral resistance after antimicrobial therapy in HSCT
  • HSCT in HIV as therapy
Canadian Journal of Infectious Diseases and Medical Microbiology
 Journal metrics
Acceptance rate27%
Submission to final decision91 days
Acceptance to publication37 days
CiteScore1.400
Impact Factor1.373